It is definitely a strong contender.

Pfizer posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products showed growth. Older top-selling drugs, including its ...

With an annual dividend yield of 6.96%, Pfizer Inc. (NYSE:PFE) is included among the 12 Best S&P 500 Stocks to Buy for Dividends. Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, ...

Pfizers approaching patent cliff and expanding pipeline remain central as the pharmaceutical group advances oncology programs ...

Pfizer draws attention as healthcare steadies a mixed market, supported by oncology progress, vaccine development and ...

Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year outlook as its Covid vaccine and antiviral pill Paxlovid helped boost sales. It ...

Pfizer stock currently trades at less than 9 times forward earnings while yielding more than 6%, making it one of the cheapest large-cap pharmaceutical stocks on the market. That immediately gets ...